The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials

BACKGROUND: Abiraterone acetate, a CYP17 enzyme inhibitor, can block the synthesis of androgens in the adrenal gland, prostate, and testis. The purpose of this study was to investigate the efficacy and safety of abiraterone acetate in high-risk prostate cancer patients, including metastatic castrati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Androl Urol
Main Authors: Tan, Guobin, Xuan, Zijun, Li, Zhiqin, Huang, Shuitong, Chen, Guangming, Wu, Yonglu, Chen, Xianxi, Liang, Zhijin, Wu, Aiming
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475664/
https://ncbi.nlm.nih.gov/pubmed/32944530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1058
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares